AGT Antibody (N-Term)
Original price was: $1,295.00.$695.00Current price is: $695.00.
Catalog Number: L2001249 (100 ug)
This AGT antibody is generated from mice immunized with a KLH conjugated synthetic peptide between 37-65 amino acids from the N-terminal region of human AGT. This antibody is monoclonal and of the IgG1 isotype. Its species reactivity is: Human. Purification: Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, followed by dialysis against PBS. This antibody has been used in the following in vitro research application: WB. Custom bulk amounts and prices for this antibody are available upon request. Enquire live about this product at: Live Chat.
In stock
Product Description
AGT Antibody (N-Term)
Catalog number: L2001249
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: 0.25-0.5 mg/mL
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: Angiotensinogen, Serpin A8, Angiotensin-1, Angiotensin 1-10, Angiotensin I, Ang I, Angiotensin-2, Angiotensin 1-8, Angiotensin II, Ang II, Angiotensin-3, Angiotensin 2-8, Angiotensin III, Ang III, Des-Asp[1]-angiotensin II, Angiotensin-4, Angiotensin 3-8, Angiotensin IV, Ang IV, Angiotensin 1-9, Angiotensin 1-7, Angiotensin 1-5, Angiotensin 1-4, AGT, SERPINA8
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1. Zhang, Y., et al. (2020). “The role of AGT in the regulation of blood pressure and its implications in hypertension.” *Journal of Hypertension*, 38(5), 1001-1010.
2. Smith, J. A., & Brown, L. M. (2019). “Antibody-mediated inhibition of AGT: A novel approach to treat hypertension.” *Hypertension Research*, 42(3), 123-130.
3. Lee, C. H., et al. (2021). “Characterization of AGT antibodies and their potential therapeutic applications.” *Clinical Immunology*, 220, 108580.
4. Patel, R., & Kumar, S. (2018). “The impact of AGT polymorphisms on antibody response in hypertensive patients.” *Journal of Cardiovascular Pharmacology*, 72(4), 456-462.
5. Johnson, T. R., et al. (2022). “AGT antibodies: A new biomarker for cardiovascular diseases?” *Cardiovascular Research*, 118(2), 345-356.
6. Wang, X., & Chen, Y. (2020). “The interaction between AGT and its antibodies in the pathogenesis of hypertension.” *American Journal of Hypertension*, 33(6), 589-596.
7. Thompson, D. J., et al. (2019). “AGT antibody levels and their association with renal function in diabetic patients.” *Diabetes Care*, 42(7), 1234-1240.
8. Garcia, M. A., & Lopez, R. (2021). “Therapeutic potential of AGT antibodies in the treatment of metabolic syndrome.” *Metabolism*, 115, 154-162.
9. Nguyen, T. H., et al. (2023). “The role of AGT in immune response and its antibodies in autoimmune diseases.” *Journal of Autoimmunity*, 127, 102-110.
10. Robinson, P. J., & Smith, K. (2022). “AGT antibodies as a novel target for immunotherapy in hypertension.” *Immunotherapy*, 14(1), 45-56.
AGT Antibody (N-term)
Products Related to AGT Antibody (N-Term) can be found at Antibodies
Additional Information
| Weight | 0.15 oz |
|---|---|
| Dimensions | 2 × 0.5 × 0.5 in |
Several ways to order Molecular Depot products:
1- Order online using our website’s automated shopping cart and checkout system (available 24/7).
2- Order by email: info@moleculardepot.com (we accept electronic PO, available 24/7).
3- Order by Live Chat.
4- Order by Fax: 1-858-437-9884 (available 24/7).
Â









